We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05232825
Brief Title: A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis (Ocarina II)

First Submitted : January 27, 2022
First Submitted that Met QC Criteria : January 31, 2022
First Posted : February 10, 2022

Last Update Submitted that Met QC Criteria : January 13, 2023
Last Update Posted : January 17, 2023